SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity.

ABSTRACT:

SUBMITTER: Anft M 

PROVIDER: S-EPMC9624106 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature